nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—Sulfapyridine—Vismodegib—skin cancer	0.436	1	CrCrCtD
Sulfamethoxazole—ALB—Vismodegib—skin cancer	0.0802	0.183	CbGbCtD
Sulfamethoxazole—ALB—Vemurafenib—skin cancer	0.0634	0.144	CbGbCtD
Sulfamethoxazole—CYP2C8—Vismodegib—skin cancer	0.062	0.141	CbGbCtD
Sulfamethoxazole—CYP2C9—Vismodegib—skin cancer	0.0432	0.0985	CbGbCtD
Sulfamethoxazole—CYP3A4—Temozolomide—skin cancer	0.0363	0.0826	CbGbCtD
Sulfamethoxazole—CYP3A4—Imiquimod—skin cancer	0.0363	0.0826	CbGbCtD
Sulfamethoxazole—ALB—Fluorouracil—skin cancer	0.0285	0.0649	CbGbCtD
Sulfamethoxazole—CYP3A4—Vismodegib—skin cancer	0.0251	0.0573	CbGbCtD
Sulfamethoxazole—CYP2C8—Fluorouracil—skin cancer	0.022	0.0501	CbGbCtD
Sulfamethoxazole—CYP3A4—Vemurafenib—skin cancer	0.0199	0.0453	CbGbCtD
Sulfamethoxazole—CYP2C9—Fluorouracil—skin cancer	0.0153	0.035	CbGbCtD
Sulfamethoxazole—CYP3A4—Docetaxel—skin cancer	0.00682	0.0155	CbGbCtD
Sulfamethoxazole—Vomiting—Vismodegib—skin cancer	0.000436	0.00348	CcSEcCtD
Sulfamethoxazole—Rash—Vismodegib—skin cancer	0.000432	0.00345	CcSEcCtD
Sulfamethoxazole—Dermatitis—Vismodegib—skin cancer	0.000432	0.00345	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Bleomycin—skin cancer	0.000428	0.00342	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Vemurafenib—skin cancer	0.000423	0.00338	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Vemurafenib—skin cancer	0.000415	0.00332	CcSEcCtD
Sulfamethoxazole—Ataxia—Temozolomide—skin cancer	0.000414	0.00331	CcSEcCtD
Sulfamethoxazole—Skin disorder—Vemurafenib—skin cancer	0.000411	0.00329	CcSEcCtD
Sulfamethoxazole—Nausea—Vismodegib—skin cancer	0.000407	0.00325	CcSEcCtD
Sulfamethoxazole—Pneumonia—Bleomycin—skin cancer	0.000404	0.00323	CcSEcCtD
Sulfamethoxazole—Angioedema—Imiquimod—skin cancer	0.000404	0.00323	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Dactinomycin—skin cancer	0.000399	0.00319	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.000396	0.00317	CcSEcCtD
Sulfamethoxazole—Neutropenia—Dactinomycin—skin cancer	0.000393	0.00314	CcSEcCtD
Sulfamethoxazole—Stomatitis—Bleomycin—skin cancer	0.000392	0.00313	CcSEcCtD
Sulfamethoxazole—Cough—Imiquimod—skin cancer	0.000386	0.00308	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000386	0.00308	CcSEcCtD
Sulfamethoxazole—Convulsion—Imiquimod—skin cancer	0.000383	0.00306	CcSEcCtD
Sulfamethoxazole—Ataxia—Fluorouracil—skin cancer	0.000381	0.00305	CcSEcCtD
Sulfamethoxazole—Pneumonia—Dactinomycin—skin cancer	0.000377	0.00301	CcSEcCtD
Sulfamethoxazole—Arthralgia—Imiquimod—skin cancer	0.000377	0.00301	CcSEcCtD
Sulfamethoxazole—Myalgia—Imiquimod—skin cancer	0.000377	0.00301	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000374	0.00299	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000372	0.00297	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Vemurafenib—skin cancer	0.000368	0.00294	CcSEcCtD
Sulfamethoxazole—Stomatitis—Dactinomycin—skin cancer	0.000366	0.00292	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000365	0.00292	CcSEcCtD
Sulfamethoxazole—Fatigue—Vemurafenib—skin cancer	0.000365	0.00292	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Temozolomide—skin cancer	0.000361	0.00289	CcSEcCtD
Sulfamethoxazole—Neutropenia—Temozolomide—skin cancer	0.000356	0.00284	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Imiquimod—skin cancer	0.000354	0.00283	CcSEcCtD
Sulfamethoxazole—Skin disorder—Imiquimod—skin cancer	0.000351	0.0028	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Dactinomycin—skin cancer	0.00035	0.0028	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Temozolomide—skin cancer	0.000347	0.00277	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Fluorouracil—skin cancer	0.000347	0.00277	CcSEcCtD
Sulfamethoxazole—Anorexia—Imiquimod—skin cancer	0.000344	0.00275	CcSEcCtD
Sulfamethoxazole—Pneumonia—Temozolomide—skin cancer	0.000341	0.00273	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Temozolomide—skin cancer	0.000339	0.00271	CcSEcCtD
Sulfamethoxazole—Infestation—Temozolomide—skin cancer	0.000339	0.00271	CcSEcCtD
Sulfamethoxazole—Depression—Temozolomide—skin cancer	0.000338	0.0027	CcSEcCtD
Sulfamethoxazole—Hepatitis—Dactinomycin—skin cancer	0.000337	0.00269	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000336	0.00269	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Vemurafenib—skin cancer	0.000335	0.00267	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Fluorouracil—skin cancer	0.000333	0.00266	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Temozolomide—skin cancer	0.000332	0.00266	CcSEcCtD
Sulfamethoxazole—Stomatitis—Temozolomide—skin cancer	0.000331	0.00264	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000329	0.00263	CcSEcCtD
Sulfamethoxazole—Insomnia—Imiquimod—skin cancer	0.000326	0.00261	CcSEcCtD
Sulfamethoxazole—Chills—Bleomycin—skin cancer	0.000324	0.00259	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Imiquimod—skin cancer	0.000322	0.00257	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Temozolomide—skin cancer	0.000321	0.00256	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Fluorouracil—skin cancer	0.00032	0.00256	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Dactinomycin—skin cancer	0.000318	0.00254	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Imiquimod—skin cancer	0.000318	0.00254	CcSEcCtD
Sulfamethoxazole—Pneumonia—Fluorouracil—skin cancer	0.000314	0.00251	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Imiquimod—skin cancer	0.000314	0.00251	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Fluorouracil—skin cancer	0.000312	0.0025	CcSEcCtD
Sulfamethoxazole—Infestation—Fluorouracil—skin cancer	0.000312	0.0025	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Vemurafenib—skin cancer	0.000312	0.00249	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Imiquimod—skin cancer	0.000312	0.00249	CcSEcCtD
Sulfamethoxazole—Fatigue—Imiquimod—skin cancer	0.000311	0.00249	CcSEcCtD
Sulfamethoxazole—Renal impairment—Docetaxel—skin cancer	0.000308	0.00246	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Fluorouracil—skin cancer	0.000306	0.00245	CcSEcCtD
Sulfamethoxazole—Stomatitis—Fluorouracil—skin cancer	0.000305	0.00243	CcSEcCtD
Sulfamethoxazole—Hepatitis—Temozolomide—skin cancer	0.000304	0.00243	CcSEcCtD
Sulfamethoxazole—Asthenia—Vemurafenib—skin cancer	0.000304	0.00243	CcSEcCtD
Sulfamethoxazole—Hallucination—Temozolomide—skin cancer	0.000303	0.00242	CcSEcCtD
Sulfamethoxazole—Chills—Dactinomycin—skin cancer	0.000302	0.00241	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Temozolomide—skin cancer	0.000301	0.0024	CcSEcCtD
Sulfamethoxazole—Pruritus—Vemurafenib—skin cancer	0.000299	0.00239	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Temozolomide—skin cancer	0.000299	0.00239	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Temozolomide—skin cancer	0.000298	0.00238	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Imiquimod—skin cancer	0.000295	0.00236	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Docetaxel—skin cancer	0.000294	0.00235	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Fluorouracil—skin cancer	0.000292	0.00233	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Vemurafenib—skin cancer	0.00029	0.00231	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Temozolomide—skin cancer	0.000288	0.0023	CcSEcCtD
Sulfamethoxazole—Urticaria—Imiquimod—skin cancer	0.000287	0.00229	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Imiquimod—skin cancer	0.000285	0.00228	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Imiquimod—skin cancer	0.000285	0.00228	CcSEcCtD
Sulfamethoxazole—Eye disorder—Temozolomide—skin cancer	0.000285	0.00227	CcSEcCtD
Sulfamethoxazole—Tinnitus—Temozolomide—skin cancer	0.000284	0.00227	CcSEcCtD
Sulfamethoxazole—Leukopenia—Bleomycin—skin cancer	0.000281	0.00225	CcSEcCtD
Sulfamethoxazole—Dizziness—Vemurafenib—skin cancer	0.00028	0.00224	CcSEcCtD
Sulfamethoxazole—Ataxia—Docetaxel—skin cancer	0.000275	0.0022	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Temozolomide—skin cancer	0.000275	0.0022	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Temozolomide—skin cancer	0.000274	0.00219	CcSEcCtD
Sulfamethoxazole—Cough—Bleomycin—skin cancer	0.000274	0.00219	CcSEcCtD
Sulfamethoxazole—Chills—Temozolomide—skin cancer	0.000273	0.00218	CcSEcCtD
Sulfamethoxazole—Vomiting—Vemurafenib—skin cancer	0.000269	0.00215	CcSEcCtD
Sulfamethoxazole—Myalgia—Bleomycin—skin cancer	0.000268	0.00214	CcSEcCtD
Sulfamethoxazole—Rash—Vemurafenib—skin cancer	0.000267	0.00213	CcSEcCtD
Sulfamethoxazole—Mental disorder—Temozolomide—skin cancer	0.000267	0.00213	CcSEcCtD
Sulfamethoxazole—Dermatitis—Vemurafenib—skin cancer	0.000267	0.00213	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Imiquimod—skin cancer	0.000266	0.00213	CcSEcCtD
Sulfamethoxazole—Headache—Vemurafenib—skin cancer	0.000265	0.00212	CcSEcCtD
Sulfamethoxazole—Malnutrition—Temozolomide—skin cancer	0.000265	0.00212	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000264	0.00211	CcSEcCtD
Sulfamethoxazole—Leukopenia—Dactinomycin—skin cancer	0.000262	0.0021	CcSEcCtD
Sulfamethoxazole—Asthenia—Imiquimod—skin cancer	0.000259	0.00207	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Bleomycin—skin cancer	0.000256	0.00205	CcSEcCtD
Sulfamethoxazole—Pruritus—Imiquimod—skin cancer	0.000255	0.00204	CcSEcCtD
Sulfamethoxazole—Nausea—Vemurafenib—skin cancer	0.000251	0.00201	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Bleomycin—skin cancer	0.000251	0.00201	CcSEcCtD
Sulfamethoxazole—Myalgia—Dactinomycin—skin cancer	0.000249	0.00199	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Imiquimod—skin cancer	0.000247	0.00197	CcSEcCtD
Sulfamethoxazole—Anorexia—Bleomycin—skin cancer	0.000244	0.00195	CcSEcCtD
Sulfamethoxazole—Angioedema—Temozolomide—skin cancer	0.000242	0.00194	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Docetaxel—skin cancer	0.00024	0.00192	CcSEcCtD
Sulfamethoxazole—Dizziness—Imiquimod—skin cancer	0.000239	0.00191	CcSEcCtD
Sulfamethoxazole—Vertigo—Temozolomide—skin cancer	0.000238	0.0019	CcSEcCtD
Sulfamethoxazole—Leukopenia—Temozolomide—skin cancer	0.000237	0.0019	CcSEcCtD
Sulfamethoxazole—Neutropenia—Docetaxel—skin cancer	0.000237	0.00189	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Dactinomycin—skin cancer	0.000234	0.00187	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000234	0.00187	CcSEcCtD
Sulfamethoxazole—Cough—Temozolomide—skin cancer	0.000231	0.00185	CcSEcCtD
Sulfamethoxazole—Convulsion—Temozolomide—skin cancer	0.00023	0.00184	CcSEcCtD
Sulfamethoxazole—Vomiting—Imiquimod—skin cancer	0.00023	0.00183	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Bleomycin—skin cancer	0.000229	0.00183	CcSEcCtD
Sulfamethoxazole—Anorexia—Dactinomycin—skin cancer	0.000228	0.00182	CcSEcCtD
Sulfamethoxazole—Rash—Imiquimod—skin cancer	0.000228	0.00182	CcSEcCtD
Sulfamethoxazole—Dermatitis—Imiquimod—skin cancer	0.000227	0.00182	CcSEcCtD
Sulfamethoxazole—Pneumonia—Docetaxel—skin cancer	0.000227	0.00181	CcSEcCtD
Sulfamethoxazole—Headache—Imiquimod—skin cancer	0.000226	0.00181	CcSEcCtD
Sulfamethoxazole—Arthralgia—Temozolomide—skin cancer	0.000226	0.0018	CcSEcCtD
Sulfamethoxazole—Myalgia—Temozolomide—skin cancer	0.000226	0.0018	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Docetaxel—skin cancer	0.000226	0.0018	CcSEcCtD
Sulfamethoxazole—Infestation—Docetaxel—skin cancer	0.000226	0.0018	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000224	0.00179	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000224	0.00179	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Bleomycin—skin cancer	0.000223	0.00178	CcSEcCtD
Sulfamethoxazole—Renal failure—Docetaxel—skin cancer	0.000222	0.00177	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Docetaxel—skin cancer	0.000221	0.00177	CcSEcCtD
Sulfamethoxazole—Stomatitis—Docetaxel—skin cancer	0.00022	0.00176	CcSEcCtD
Sulfamethoxazole—Leukopenia—Fluorouracil—skin cancer	0.000219	0.00175	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000218	0.00174	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Temozolomide—skin cancer	0.000216	0.00173	CcSEcCtD
Sulfamethoxazole—Nausea—Imiquimod—skin cancer	0.000214	0.00171	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Docetaxel—skin cancer	0.000213	0.0017	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Temozolomide—skin cancer	0.000212	0.0017	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Temozolomide—skin cancer	0.000212	0.00169	CcSEcCtD
Sulfamethoxazole—Convulsion—Fluorouracil—skin cancer	0.000212	0.00169	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Docetaxel—skin cancer	0.00021	0.00168	CcSEcCtD
Sulfamethoxazole—Skin disorder—Temozolomide—skin cancer	0.00021	0.00168	CcSEcCtD
Sulfamethoxazole—Myalgia—Fluorouracil—skin cancer	0.000208	0.00166	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Dactinomycin—skin cancer	0.000208	0.00166	CcSEcCtD
Sulfamethoxazole—Fatigue—Dactinomycin—skin cancer	0.000206	0.00165	CcSEcCtD
Sulfamethoxazole—Anorexia—Temozolomide—skin cancer	0.000206	0.00165	CcSEcCtD
Sulfamethoxazole—Urticaria—Bleomycin—skin cancer	0.000204	0.00163	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Bleomycin—skin cancer	0.000203	0.00162	CcSEcCtD
Sulfamethoxazole—Hepatitis—Docetaxel—skin cancer	0.000202	0.00162	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Docetaxel—skin cancer	0.0002	0.0016	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Fluorouracil—skin cancer	0.000199	0.00159	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Docetaxel—skin cancer	0.000199	0.00159	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Docetaxel—skin cancer	0.000198	0.00159	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000197	0.00157	CcSEcCtD
Sulfamethoxazole—Insomnia—Temozolomide—skin cancer	0.000196	0.00156	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Dactinomycin—skin cancer	0.000196	0.00156	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Fluorouracil—skin cancer	0.000195	0.00156	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Fluorouracil—skin cancer	0.000195	0.00156	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Temozolomide—skin cancer	0.000193	0.00154	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Docetaxel—skin cancer	0.000191	0.00153	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Temozolomide—skin cancer	0.00019	0.00152	CcSEcCtD
Sulfamethoxazole—Anorexia—Fluorouracil—skin cancer	0.00019	0.00152	CcSEcCtD
Sulfamethoxazole—Eye disorder—Docetaxel—skin cancer	0.000189	0.00151	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Dactinomycin—skin cancer	0.000189	0.00151	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Dactinomycin—skin cancer	0.000189	0.00151	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Bleomycin—skin cancer	0.000189	0.00151	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Temozolomide—skin cancer	0.000188	0.0015	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Temozolomide—skin cancer	0.000187	0.00149	CcSEcCtD
Sulfamethoxazole—Fatigue—Temozolomide—skin cancer	0.000186	0.00149	CcSEcCtD
Sulfamethoxazole—Asthenia—Bleomycin—skin cancer	0.000184	0.00147	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Docetaxel—skin cancer	0.000183	0.00146	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Docetaxel—skin cancer	0.000182	0.00146	CcSEcCtD
Sulfamethoxazole—Chills—Docetaxel—skin cancer	0.000182	0.00145	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000182	0.00145	CcSEcCtD
Sulfamethoxazole—Pruritus—Bleomycin—skin cancer	0.000181	0.00145	CcSEcCtD
Sulfamethoxazole—Insomnia—Fluorouracil—skin cancer	0.00018	0.00144	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Fluorouracil—skin cancer	0.000178	0.00142	CcSEcCtD
Sulfamethoxazole—Mental disorder—Docetaxel—skin cancer	0.000177	0.00142	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Temozolomide—skin cancer	0.000177	0.00141	CcSEcCtD
Sulfamethoxazole—Malnutrition—Docetaxel—skin cancer	0.000176	0.00141	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Dactinomycin—skin cancer	0.000176	0.00141	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Fluorouracil—skin cancer	0.000175	0.0014	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Fluorouracil—skin cancer	0.000173	0.00138	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000172	0.00137	CcSEcCtD
Sulfamethoxazole—Urticaria—Temozolomide—skin cancer	0.000172	0.00137	CcSEcCtD
Sulfamethoxazole—Asthenia—Dactinomycin—skin cancer	0.000172	0.00137	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Temozolomide—skin cancer	0.000171	0.00137	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Temozolomide—skin cancer	0.000171	0.00137	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Dactinomycin—skin cancer	0.000164	0.00131	CcSEcCtD
Sulfamethoxazole—Vomiting—Bleomycin—skin cancer	0.000163	0.0013	CcSEcCtD
Sulfamethoxazole—Rash—Bleomycin—skin cancer	0.000162	0.00129	CcSEcCtD
Sulfamethoxazole—Dermatitis—Bleomycin—skin cancer	0.000162	0.00129	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Temozolomide—skin cancer	0.000159	0.00127	CcSEcCtD
Sulfamethoxazole—Urticaria—Fluorouracil—skin cancer	0.000158	0.00127	CcSEcCtD
Sulfamethoxazole—Leukopenia—Docetaxel—skin cancer	0.000158	0.00126	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Fluorouracil—skin cancer	0.000158	0.00126	CcSEcCtD
Sulfamethoxazole—Asthenia—Temozolomide—skin cancer	0.000155	0.00124	CcSEcCtD
Sulfamethoxazole—Cough—Docetaxel—skin cancer	0.000154	0.00123	CcSEcCtD
Sulfamethoxazole—Pruritus—Temozolomide—skin cancer	0.000153	0.00122	CcSEcCtD
Sulfamethoxazole—Convulsion—Docetaxel—skin cancer	0.000153	0.00122	CcSEcCtD
Sulfamethoxazole—Nausea—Bleomycin—skin cancer	0.000152	0.00122	CcSEcCtD
Sulfamethoxazole—Vomiting—Dactinomycin—skin cancer	0.000152	0.00122	CcSEcCtD
Sulfamethoxazole—Rash—Dactinomycin—skin cancer	0.000151	0.0012	CcSEcCtD
Sulfamethoxazole—Arthralgia—Docetaxel—skin cancer	0.00015	0.0012	CcSEcCtD
Sulfamethoxazole—Myalgia—Docetaxel—skin cancer	0.00015	0.0012	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000149	0.00119	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Temozolomide—skin cancer	0.000148	0.00118	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Fluorouracil—skin cancer	0.000147	0.00117	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Docetaxel—skin cancer	0.000144	0.00115	CcSEcCtD
Sulfamethoxazole—Dizziness—Temozolomide—skin cancer	0.000143	0.00114	CcSEcCtD
Sulfamethoxazole—Nausea—Dactinomycin—skin cancer	0.000142	0.00114	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Docetaxel—skin cancer	0.000141	0.00113	CcSEcCtD
Sulfamethoxazole—Pruritus—Fluorouracil—skin cancer	0.000141	0.00113	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Docetaxel—skin cancer	0.000141	0.00113	CcSEcCtD
Sulfamethoxazole—Skin disorder—Docetaxel—skin cancer	0.00014	0.00112	CcSEcCtD
Sulfamethoxazole—Vomiting—Temozolomide—skin cancer	0.000138	0.0011	CcSEcCtD
Sulfamethoxazole—Anorexia—Docetaxel—skin cancer	0.000137	0.0011	CcSEcCtD
Sulfamethoxazole—Rash—Temozolomide—skin cancer	0.000136	0.00109	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Fluorouracil—skin cancer	0.000136	0.00109	CcSEcCtD
Sulfamethoxazole—Dermatitis—Temozolomide—skin cancer	0.000136	0.00109	CcSEcCtD
Sulfamethoxazole—Headache—Temozolomide—skin cancer	0.000136	0.00108	CcSEcCtD
Sulfamethoxazole—Dizziness—Fluorouracil—skin cancer	0.000132	0.00105	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000131	0.00105	CcSEcCtD
Sulfamethoxazole—Insomnia—Docetaxel—skin cancer	0.00013	0.00104	CcSEcCtD
Sulfamethoxazole—Nausea—Temozolomide—skin cancer	0.000128	0.00103	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Docetaxel—skin cancer	0.000128	0.00102	CcSEcCtD
Sulfamethoxazole—Vomiting—Fluorouracil—skin cancer	0.000127	0.00101	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Docetaxel—skin cancer	0.000127	0.00101	CcSEcCtD
Sulfamethoxazole—Rash—Fluorouracil—skin cancer	0.000126	0.001	CcSEcCtD
Sulfamethoxazole—Dermatitis—Fluorouracil—skin cancer	0.000126	0.001	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Docetaxel—skin cancer	0.000125	0.000999	CcSEcCtD
Sulfamethoxazole—Headache—Fluorouracil—skin cancer	0.000125	0.000998	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Docetaxel—skin cancer	0.000124	0.000992	CcSEcCtD
Sulfamethoxazole—Fatigue—Docetaxel—skin cancer	0.000124	0.000991	CcSEcCtD
Sulfamethoxazole—Nausea—Fluorouracil—skin cancer	0.000118	0.000946	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Docetaxel—skin cancer	0.000118	0.00094	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Docetaxel—skin cancer	0.000114	0.000909	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Docetaxel—skin cancer	0.000114	0.000909	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Docetaxel—skin cancer	0.000106	0.000847	CcSEcCtD
Sulfamethoxazole—Asthenia—Docetaxel—skin cancer	0.000103	0.000825	CcSEcCtD
Sulfamethoxazole—Pruritus—Docetaxel—skin cancer	0.000102	0.000813	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Docetaxel—skin cancer	9.84e-05	0.000786	CcSEcCtD
Sulfamethoxazole—Dizziness—Docetaxel—skin cancer	9.51e-05	0.00076	CcSEcCtD
Sulfamethoxazole—Vomiting—Docetaxel—skin cancer	9.15e-05	0.000731	CcSEcCtD
Sulfamethoxazole—Rash—Docetaxel—skin cancer	9.07e-05	0.000725	CcSEcCtD
Sulfamethoxazole—Dermatitis—Docetaxel—skin cancer	9.06e-05	0.000724	CcSEcCtD
Sulfamethoxazole—Headache—Docetaxel—skin cancer	9.01e-05	0.00072	CcSEcCtD
Sulfamethoxazole—Nausea—Docetaxel—skin cancer	8.54e-05	0.000683	CcSEcCtD
